Wanifuchi-Endo Yumi

Affiliation and department：

Research field (1)： General surgery, pediatric surgery

Research keywords (1)：乳癌

Research theme for competitive and other funds (12)：

2022 - 2025 アミノ酸トランスポーターを標的としたホルモン抵抗性乳がんに対する新規治療法の開発
2021 - 2024 ミトコンドリア呼吸調節因子を標的とした乳がんに対する革新的治療法の開発
2019 - 2022 Discovering novel mechanisms of taxane resistance in human breast cancer
2018 - 2021 糖代謝を標的とした治療抵抗性乳癌に対する新規分子標的治療薬の開発
2017 - 2020 乳癌に対する新規治療薬の開発を目的としたマイクロRNA-569ノックダウン療法

Show all

Papers (120)：

Maho Kusudo, Mitsuo Terada, Nari Kureyama, Yumi Wanifuchi-Endo, Takashi Fujita, Tomoko Asano, Akiko Kato, Makiko Mori, Nanae Horisawa, Tatsuya Toyama. Characterizing user demographics in posts related to breast, lung and colon cancer on Japanese twitter (X). Scientific reports. 2024. 14. 1. 6485-6485
Nari Kureyama, Mitsuo Terada, Maho Kusudo, Kazuki Nozawa, Yumi Wanifuchi-Endo, Takashi Fujita, Tomoko Asano, Akiko Kato, Makiko Mori, Nanae Horisawa, et al. Fact-Checking Cancer Information on Social Media in Japan: Retrospective Study Using Twitter. JMIR formative research. 2023. 7. e49452
Akiko Kato, Naoto Kondo, Yumi Wanifuchi-Endo, Takashi Fujita, Tomoko Asano, Tomoka Hisada, Yasuaki Uemoto, Mitsuo Terada, Hiroyuki Kato, Masayuki Komura, et al. Low TINAGL1 expression is a marker for poor prognosis in breast cancer. Journal of cancer research and clinical oncology. 2023. 149. 8. 4771-4782
Tomoka Hisada, Naoto Kondo, Yumi Wanifuchi-Endo, Satoshi Osaga, Takashi Fujita, Tomoko Asano, Yasuaki Uemoto, Sayaka Nishikawa, Yusuke Katagiri, Mitsuo Terada, et al. Co-expression effect of LLGL2 and SLC7A5 to predict prognosis in ERα-positive breast cancer. Scientific reports. 2022. 12. 1. 16515-16515
Mitsuo Terada, Naoto Kondo, Yumi Wanifuchi-Endo, Takashi Fujita, Tomoko Asano, Tomoka Hisada, Yasuaki Uemoto, Akiko Kato, Natsumi Yamanaka, Hiroshi Sugiura, et al. Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: a multi-center prospective observational study. Breast cancer research and treatment. 2022. 195. 3. 311-323

ｍore...

MISC (18)：

Akiko Ogiya, Kieko Yamazaki, Rie Horii, Tadahiko Shien, Yoshiya Horimoto, Norikazu Masuda, Touko Inao, Mitsuchika Hosoda, Naoko Ishida, Tomofumi Osako, et al. Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer (vol 24, pg 473, 2017). BREAST CANCER. 2017. 24. 4. 642-642
Nobuyasu Yoshimoto, Yu Dong, Hiroshi Sugiura, Mitsuo Terada, Naoto Kondo, Yumi Endo, Hiroko Yamashita, Tatsuya Toyama. Study to determine whether SNPs in CYP17A1, ESR1, and TNRC9 loci correlate with increased breast cancer risk and serum 25-OH vitamin D levels. JOURNAL OF CLINICAL ONCOLOGY. 2017. 35
Y. Endo, Y. Dong, N. Kondo, Y. Hato, T. Hisada, M. Nishimoto, S. Nishikawa, S. Takahashi, T. Toyama. Exome sequencing of human breast cancer tissues resistant to taxanes. CANCER RESEARCH. 2017. 77
Y. Miyoshi, T. Shien, A. Ogiya, N. Ishida, K. Yamazaki, R. Horii, Y. Horimoto, N. Masuda, H. Yasojima, T. Inao, et al. Prognostic value of aldehyde dehydrogenase 1 (ALDH1) and tumor infiltrating lymphocytes (TIL) to predict the late recurrence in ER positive, HER2 negative breast cancer. CANCER RESEARCH. 2016. 76
Yukari Hato, Yumi Endo, Nobuyasu Yoshimoto, Tomoko Asano, Mina Yamaguchi, Satoru Takahashi, Tatsuya Toyama. Prognostic impact of single-nucleotide polymorphisms (SNPs) in or near the ZNF423 and CTSO genes in estrogen receptor (ER) - positive breast cancer patients receiving adjuvant endocrine therapy. CANCER RESEARCH. 2015. 75

ｍore...

Education (2)：

2010 - 2013 Nagoya City University
- 2003 Gunma University

Professional career (1)：

博士 (名古屋市立大学医学研究科)

Work history (2)：

2016/09 - 現在 Nagoya City University
2013/04 - 2016/08 Nagoya City University

Awards (1)：

2016/06 - The Japanese Breast Cancer Society Research Award

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page